Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-HF: CA125-guided Diuretic Therapy in Acute Heart Failure
NCT02643147Phase 4Completed
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide in Acute Heart Failure (AHF), sponsored by INCLIVA Biomedical Research Institute. Started Jan 2015; status: completed.
02
Drugs
furosemide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT02643147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643147.